Breaking News Instant updates and real-time market news.

ARA

American Renal Associates

$18.10

0.52 (2.96%)

, DVA

DaVita

$62.66

0.66 (1.06%)

07:51
10/13/16
10/13
07:51
10/13/16
07:51

Price targets cut on dialysis stocks at SunTrust

SunTrust analyst David MacDonald lowered his price targets on dialysis stocks, citing CMS' recent request for information and resulting payor risk and lower assumed multiples. The analyst cut his price target on American Renal Associates (ARA) to $24 from $34, on DaVita (DVA) to $66 from $80 and on Fresenius Medical (FMS) to $48 from $54. He maintains Buy ratings on American Renal and Fresenius but said he does not expect the stocks to rise significantly until the CMS matter is resolved. MacDonald keeps a Hold rating on DaVita.

ARA

American Renal Associates

$18.10

0.52 (2.96%)

DVA

DaVita

$62.66

0.66 (1.06%)

FMS

Fresenius Medical

$41.26

-0.11 (-0.27%)

  • 02

    Nov

  • 06

    Nov

ARA American Renal Associates
$18.10

0.52 (2.96%)

05/16/16
05/16/16
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Alaska Air (ALK) reinstated with an Outperform at Cowen as the firm believes the shares have been unfairly punished over the past quarter and noted their April unit revenue results exceeded expectations. 2. Microsoft (MSFT) initiated with a Hold at Canaccord citing risk-reward is balanced near-term. 3. lululemon (LULU) reinstated with an Underperform at BofA/Merril by analyst Rafe Jadrosich, who said he sees downside to street estimates. The analyst has a lower sales and margin outlook due to intensifying competition and ongoing investments to support international expansion. 4. American Renal Associations (ARA) initiated with a Buy at SunTrust, an Outperform at Wells Fargo, an Overweight at Barclays, and a Neutral at Goldman. MGM Growth (MGP) initiated with a Buy at BofA/Merrill, Deutsche Bank and SunTrust. It was also initiated with a Neutral at Citi, and an Overweight at JPMorgan and Morgan Stanley. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
05/16/16
WELS
05/16/16
INITIATION
WELS
Outperform
American Renal Associates initiated with an Outperform at Wells Fargo
Wells Fargo analyst Gary Lieberman started American Renal Associates Holdings with an Outperform rating and $30-$34 price target range.
05/16/16
RHCO
05/16/16
INITIATION
Target $34
RHCO
Buy
American Renal Associates initiated with a Buy at SunTrust
Target $34.
05/16/16
GSCO
05/16/16
INITIATION
Target $30
GSCO
Neutral
American Renal Associates initiated with a Neutral at Goldman
Goldman Sachs analyst Matthew Borsch started American Renal Associates Holdings with a Neutral rating and $30 price target.
DVA DaVita
$62.66

0.66 (1.06%)

09/06/16
BOFA
09/06/16
DOWNGRADE
BOFA
Neutral
DaVita downgraded to Neutral from Buy at BofA/Merrill
BofA/Merrill downgraded DaVita (DVA) to Neutral and lowered its price target to $70 saying growth rates are likely to remain muted. The firm's analyst said poor performance at HCP, Inc (HCP) is unlikely to improve in 2017 and tail risk scenarios on a CMS decision could be bigger than expected on the dialysis business.
09/06/16
09/06/16
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Biogen (BIIB) downgraded to Hold from Buy at Jefferies with analyst Brian Abrahams saying his thesis has mostly played out and that shares of Gilead Sciences (GILD) offer greater upside potential. 2. Dollar General (DG) downgraded to Neutral from Buy at Goldman with analyst Stephen Tanal saying same-store-sales have slowed and expects a modest deceleration in earnings growth and further competitive pressures. 3. comScore (SCOR) downgraded to Neutral from Buy at SunTrust with analyst Matthew Thornton saying that consensus 2017 estimates for the company are too high following its August 10 update. 4. Verifone (PAY) downgraded to Hold from Buy at Argus. 5. DaVita (DVA) downgraded to Neutral from Buy at BofA/Merrill with the firm saying growth rates are likely to remain muted. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
09/06/16
09/06/16
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Johnson Controls (JCI) initiated with a Sector Perform at RBC Capital with analyst Deane Dray saying he thinks that the company's synergies from its merger can beat expectations, but the analyst says that the stock is already "reflecting optimism." 2. DaVita (DVA) initiated with a Neutral at Citi. 3. Hershey (HSY) reinstated with a Neutral at JPMorgan. 4. Dollar Tree (DLTR) coverage assumed with a Conviction Buy at Goldman. 5. Lockheed Martin (LMT) initiated with a Buy at Citi. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
09/20/16
RAJA
09/20/16
UPGRADE
Target $75
RAJA
Outperform
DaVita upgraded to Outperform from Market Perform at Raymond James
Raymond James analyst John Ransom upgraded DaVita to Outperform and established a $75 price target. saying shares have corrected by approximately 18% following Q2 results and concerns about ACA exchange exposure. The analyst views valuation as attractive and thinks ACA exposure is a bit less than previous estimates. Further, investor expectations for DVA Medical Group are low and represent less than 10% EBIT, Ransom wrote.
FMS Fresenius Medical
$41.26

-0.11 (-0.27%)

05/09/16
BERN
05/09/16
NO CHANGE
BERN
Teva, Fresenius Medical added to recommended portfolio at Bernstein
Bernstein added Teva (TEVA) and Fresenius Medical (FMS) to its recommended portfolio of healthcare stocks. The firm says that Fresenius is not exposed to the pricing pressures affecting the sector, while Teva will allow investors to take advantage of the strong value opportunity within the pharma sector. In conjunction with its recommendation of Teva and Fresenius, Bernstein upgraded the European healthcare sector two notches, to Overweight from Underweight. The firm says that the downturn in the sector on drug pricing pressures has been overdone. According to the firm, drug prices will be pressured, but pharma stocks are currently reflecting no growth beyond 2020. Bernstein believes that outlook is overly pessimistic.
09/06/16
SBSH
09/06/16
INITIATION
SBSH
Buy
Fresenius Medical initiated with a Buy at Citi
Price target EUR 98.
09/06/16
SBSH
09/06/16
INITIATION
Target $71
SBSH
Neutral
DaVita initiated with a Neutral at Citi
Citi analyst Patrick Wood started DaVita Healthcare Partners (DVA) with a Neutral rating and $71 price target. The analyst sees limited upside to consensus estimates and prefers Fresenius Medical Care (FMS) at current share levels.
07/08/16
JEFF
07/08/16
UPGRADE
JEFF
Hold
Fresenius Medical upgraded to Hold from Underperform at Jefferies
Jefferies analyst Chris Cooper upgraded Fresenius Medical to Hold with a EUR 81 price target.

TODAY'S FREE FLY STORIES

ANET

Arista Networks

$94.41

-1.35 (-1.41%)

, CSCO

Cisco

$30.06

0.11 (0.37%)

18:32
12/09/16
12/09
18:32
12/09/16
18:32
Hot Stocks
Arista Networks favored in ITC initial determination on four of six patents »

Arista Networks (ANET)…

ANET

Arista Networks

$94.41

-1.35 (-1.41%)

CSCO

Cisco

$30.06

0.11 (0.37%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

  • 12

    Dec

  • 12

    Dec

TKTDY

Takata Corporation

$10.70

0.05 (0.47%)

18:22
12/09/16
12/09
18:22
12/09/16
18:22
Periodicals
U.S. DOT looks to accelerate pace of Takata air bag replacements, Reuters says »

The U.S. Department of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DV

DeVry

$31.90

0.9 (2.90%)

18:17
12/09/16
12/09
18:17
12/09/16
18:17
Hot Stocks
Breaking Hot Stocks news story on DeVry »

International Value…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

CSOD

Cornerstone OnDemand

$39.10

-0.11 (-0.28%)

18:10
12/09/16
12/09
18:10
12/09/16
18:10
Periodicals
Cornerstone OnDemand considers sale amid activist pressure, Bloomberg reports »

Cornerstone OnDemand has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CVM

CEL-SCI

$0.12

-0.0014 (-1.17%)

18:03
12/09/16
12/09
18:03
12/09/16
18:03
Hot Stocks
NYSE MKT says CEL-SCI noncompliant with certain listing requirements »

CEL-SCI reported on a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XOM

Exxon Mobil

$89.00

0.68 (0.77%)

18:01
12/09/16
12/09
18:01
12/09/16
18:01
Periodicals
Exxon CEO Tillerson emerges as top candidate for secretary of state, WSJ says »

Exxon Mobil CEO Rex…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FUL

H.B. Fuller

$50.36

0.05 (0.10%)

17:58
12/09/16
12/09
17:58
12/09/16
17:58
Hot Stocks
H.B. Fuller announces restructuring, to eliminate, relocate 220 positions »

H.B. Fuller has announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BIIB

Biogen

$287.77

-1.77 (-0.61%)

17:53
12/09/16
12/09
17:53
12/09/16
17:53
Periodicals
Biogen looks like a bargain, Barron's reports »

Biogen trades at just…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SNY

Sanofi

$40.40

0.63 (1.58%)

17:42
12/09/16
12/09
17:42
12/09/16
17:42
Periodicals
Sanofi to lay off 20% of U.S. diabetes, cardiovascular staff, Bloomberg says »

The layoffs include parts…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Mar

CSOD

Cornerstone OnDemand

$39.10

-0.11 (-0.28%)

17:38
12/09/16
12/09
17:38
12/09/16
17:38
Periodicals
Cornerstone OnDemand considers sale amid activist pressure, Bloomberg reports »

Investor Praesidium said…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TACO

Del Taco

$14.75

-0.39 (-2.58%)

17:34
12/09/16
12/09
17:34
12/09/16
17:34
Hot Stocks
Breaking Hot Stocks news story on Del Taco »

PW Acquisitions cuts…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Jan

  • 09

    Jan

  • 09

    Dec

UNVR

Univar

$26.36

0.54 (2.09%)

, BXLT

Baxalta

17:30
12/09/16
12/09
17:30
12/09/16
17:30
Hot Stocks
Univar names Eric Foster chief information officer »

Univar (UNVR) named Eric…

UNVR

Univar

$26.36

0.54 (2.09%)

BXLT

Baxalta

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PARN

Parnell

$1.42

-0.0031 (-0.22%)

17:30
12/09/16
12/09
17:30
12/09/16
17:30
Hot Stocks
Breaking Hot Stocks news story on Parnell 

Parnell trading resumes

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BSX

Boston Scientific

$20.81

0.2 (0.97%)

, NVRO

Nevro

$76.38

-1.88 (-2.40%)

17:24
12/09/16
12/09
17:24
12/09/16
17:24
Hot Stocks
Boston Scientific files patent infringement suit against Nevro »

Nevro (NVRO) announced…

BSX

Boston Scientific

$20.81

0.2 (0.97%)

NVRO

Nevro

$76.38

-1.88 (-2.40%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

RTN

Raytheon

$146.30

0.14 (0.10%)

17:21
12/09/16
12/09
17:21
12/09/16
17:21
Hot Stocks
Raytheon awarded $101.9M government contract »

Raytheon Co., Goleta,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CX

CEMEX

$8.77

-0.16 (-1.79%)

17:18
12/09/16
12/09
17:18
12/09/16
17:18
Hot Stocks
CEMEX receives subpoena from SEC regarding Foreign Corrupt Practices Act »

On December 9, 2016,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PDEX

PRO-DEX

$4.48

0.034 (0.76%)

17:06
12/09/16
12/09
17:06
12/09/16
17:06
Syndicate
Breaking Syndicate news story on PRO-DEX »

PRO-DEX files $25M mixed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PFBX

Peoples Financial

$14.50

-0.5 (-3.33%)

17:02
12/09/16
12/09
17:02
12/09/16
17:02
Hot Stocks
Breaking Hot Stocks news story on Peoples Financial »

Jeffrey L. Gendell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

QUIK

QuickLogic

$0.94

-0.0163 (-1.71%)

17:00
12/09/16
12/09
17:00
12/09/16
17:00
Syndicate
Breaking Syndicate news story on QuickLogic »

QuickLogic files $40M…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

STRZA

Starz

17:00
12/09/16
12/09
17:00
12/09/16
17:00
Hot Stocks
Breaking Hot Stocks news story on Starz »

Elliott Associates…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BEL

Belmond

16:55
12/09/16
12/09
16:55
12/09/16
16:55
Syndicate
Breaking Syndicate news story on Belmond »

Belmond files automatic…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PARN

Parnell

$1.42

-0.0031 (-0.22%)

16:55
12/09/16
12/09
16:55
12/09/16
16:55
Hot Stocks
Breaking Hot Stocks news story on Parnell »

Parnell trading halted,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MS

Morgan Stanley

$43.73

0.15 (0.34%)

, SHAK

Shake Shack

$38.08

0.82 (2.20%)

16:50
12/09/16
12/09
16:50
12/09/16
16:50
Hot Stocks
Breaking Hot Stocks news story on Morgan Stanley, Shake Shack »

Morgan Stanley reports…

MS

Morgan Stanley

$43.73

0.15 (0.34%)

SHAK

Shake Shack

$38.08

0.82 (2.20%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Jan

MS

Morgan Stanley

$43.73

0.15 (0.34%)

, LXFT

Luxoft

$54.40

-1.8 (-3.20%)

16:44
12/09/16
12/09
16:44
12/09/16
16:44
Hot Stocks
Breaking Hot Stocks news story on Morgan Stanley, Luxoft »

Morgan Stanley reports…

MS

Morgan Stanley

$43.73

0.15 (0.34%)

LXFT

Luxoft

$54.40

-1.8 (-3.20%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FUL

H.B. Fuller

$50.36

0.05 (0.10%)

16:44
12/09/16
12/09
16:44
12/09/16
16:44
Hot Stocks
H.B. Fuller announces restructuring plan »

On December 7, H.B.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.